Valuation: USBC, Inc.

Capitalization 220M 189M 176M 164M 306M 19.94B 329M 2.03B 800M 9.51B 824M 807M 34.72B P/E ratio 2024
-1.46x
P/E ratio 2025 -3.47x
Enterprise value 211M 182M 170M 158M 294M 19.17B 316M 1.95B 769M 9.14B 792M 776M 33.38B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
71.93%
Yield 2024 *
-
Yield 2025 -
More valuation ratios * Estimated data
Dynamic Chart
1 day-3.81%
1 week-3.72%
Current month-10.82%
1 month-19.20%
3 months-28.34%
6 months-78.31%
Current year-10.82%
More quotes
1 week 0.56
Extreme 0.563
0.61
1 month 0.56
Extreme 0.563
0.77
Current year 0.56
Extreme 0.563
0.69
1 year 0.33
Extreme 0.33
9.47
3 years 0.33
Extreme 0.33
59.2
5 years 0.33
Extreme 0.33
193.2
10 years 0.33
Extreme 0.33
397.6
More quotes
Manager TitleAgeSince
Chief Executive Officer - 05/08/2025
Chief Executive Officer 82 22/01/2023
Director of Finance/CFO 55 05/08/2025
Director TitleAgeSince
Chairman 82 31/12/2017
Director/Board Member 75 18/04/2006
Director/Board Member 67 27/12/2012
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-3.81%-3.72%-90.44%-98.97% 220M
+0.78%+0.15%-18.39%+380.28% 65.03B
+11.43%+25.61%+382.24%+2,911.46% 18.98B
+0.94%+3.66%+419.33%+122.57% 14.17B
+3.47%+1.59% - - 5.88B
+4.48%+10.21%+25.93% - 5.86B
-8.46%+2.65%+9.83%+1,221.95% 4.27B
-1.69%+0.87%-10.77% - 3.22B
Average +0.91%+5.53%+102.53%+907.46% 14.7B
Weighted average by Cap. +2.43%+5.18%+108.67%+846.70%
See all sector performances

Financials

2024 2025
Net sales - -
Net income -16.58M -14.29M -13.31M -12.39M -23.07M -1.5B -24.82M -153M -60.36M -718M -62.18M -60.9M -2.62B -22.12M -19.07M -17.76M -16.53M -30.78M -2.01B -33.11M -204M -80.53M -957M -82.96M -81.26M -3.5B
Net Debt 1.97M 1.7M 1.58M 1.47M 2.74M 179M 2.95M 18.2M 7.17M 85.31M 7.39M 7.24M 311M -8.48M -7.31M -6.8M -6.34M -11.8M -769M -12.69M -78.28M -30.87M -367M -31.8M -31.14M -1.34B
More financial data * Estimated data
Logo USBC, Inc.
Know Labs, Inc. is a developer of non-invasive diagnostics technology. The Company’s platform technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. The technology is designed to be able to integrate into a variety of wearable, mobile or bench-top form factors. Its patent-pending technology makes it possible to identify and monitor analytes that could only previously be performed by invasive and/or expensive and time-consuming lab-based tests. The Company’s expected application of the technology is focused on a product marketed as a non-invasive glucose monitor. The device is designed to provide the user with accessible and affordable real-time information on blood glucose levels. Its sensor technology embodies two key components: hardware and software. The hardware component includes a sensor which both sends and receives a radio frequency signal. The Company’s wholly owned subsidiary is Particle, Inc.
Employees
18
More about the company
Date Price Change Volume
16/01/26 0.5661 $ -3.81% 250,816
15/01/26 0.5885 $ -1.11% 157,700
14/01/26 0.5951 $ +0.46% 98,455
13/01/26 0.5924 $ -1.76% 83,877
12/01/26 0.6030 $ +2.55% 257,044

Delayed Quote Nyse, January 16, 2026 at 09:00 pm

More quotes

Quarterly revenue - Rate of surprise